RU99106244A -
APPLICATION OF 2-PHENYL-1,2-BENZISOSELENAZOLE-3 (2H) -ONE FOR PRODUCING A PHARMACEUTICAL DRUG FOR THE TREATMENT OF ALZHEIMER'S DISEASE
- Google Patents
APPLICATION OF 2-PHENYL-1,2-BENZISOSELENAZOLE-3 (2H) -ONE FOR PRODUCING A PHARMACEUTICAL DRUG FOR THE TREATMENT OF ALZHEIMER'S DISEASE
Info
Publication number
RU99106244A
RU99106244ARU99106244/14ARU99106244ARU99106244ARU 99106244 ARU99106244 ARU 99106244ARU 99106244/14 ARU99106244/14 ARU 99106244/14ARU 99106244 ARU99106244 ARU 99106244ARU 99106244 ARU99106244 ARU 99106244A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by А. НАТТЕРМАНН УНД Ко. ГМБХfiledCriticalА. НАТТЕРМАНН УНД Ко. ГМБХ
Publication of RU99106244ApublicationCriticalpatent/RU99106244A/en
1. Применение 2-фенил-1,2-бензизоселеназол-3(2Н)-она для получения фармацевтического препарата для профилактики и/или терапии деменции.1. The use of 2-phenyl-1,2-benzisoselenazole-3 (2H) -one to obtain a pharmaceutical preparation for the prevention and / or therapy of dementia. 2. Применение по п. 1 для получения фармацевтического препарата для профилактики и/или терапии сенильной деменции. 2. The use according to claim 1 for the manufacture of a pharmaceutical preparation for the prevention and / or therapy of senile dementia. 3. Применение по п.1 или 2 для получения фармацевтического препарата для профилактики и/или терапии деменции типа Альцгеймера. 3. The use according to claim 1 or 2 for the manufacture of a pharmaceutical preparation for the prophylaxis and / or therapy of Alzheimer's type dementia. 4. Фармацевтический препарат, отличающийся тем, что препарат в качестве активного вещества содержит 2-фенил-1,2-6ензизоселеназол-3(2Н)-он, и что фармацевтический препарат применим для профилактики и/или терапии болезни Альцгеймера. 4. A pharmaceutical preparation, characterized in that the preparation contains 2-phenyl-1,2-6 benzisoselenazole-3 (2H) -one as the active substance, and that the pharmaceutical preparation is applicable for the prevention and / or treatment of Alzheimer's disease. 5. Фармацевтическое средство по одному из предыдущих пунктов, отличается тем, что фармацевтическое средство применимо в виде таблеток, капсул, порошков, гранул, сиропов или инъекций. 5. The pharmaceutical agent according to one of the preceding paragraphs, characterized in that the pharmaceutical agent is applicable in the form of tablets, capsules, powders, granules, syrups or injections.
RU99106244/14A1996-08-271997-04-07
APPLICATION OF 2-PHENYL-1,2-BENZISOSELENAZOLE-3 (2H) -ONE FOR PRODUCING A PHARMACEUTICAL DRUG FOR THE TREATMENT OF ALZHEIMER'S DISEASE
RU99106244A
(en)
Use of oenotheine B for the manufacture of a medicament for the treatment of disorders related to hyperandrogenism, pharmaceutical compositions containing oenotheine B and a process for its preparation from epilobium parviflorum.
Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease and the medicament itself
Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds
NOVEL PHARMACEUTICAL COMPOSITIONS, ESPECIALLY FOR THE TREATMENT OF FUNCTIONAL COLOPATHIES, AND METHODS OF PREPARING COMPOSITIONS AND MEDICAMENTS, ESPECIALLY FOR THE TREATMENT OF THESE CONDITIONS.
Use of inhibitors of ornitine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease and process to prepare (2s,5s)-5-fluoromethylornithine
Ask the doctor. In your article on Alzheimer's disease (March, 1999), you mention" high doses of vitamin E" as helpful in slowing the progression of the condition. Specifically, what dose is recommended?